A data set from the meta-analysis of Katzenschlager et al. (2021). Specifically, this data set corresponds to the meta-analysis comparing aspartate transaminase (ASAT) levels of COVID-19 infected patients who died and those who survived. The unit of measurement for the ASAT levels is U/L. The rows in the data set correspond to the primary studies.
dat.asat_rawA data frame with 27 rows and 13 columns:
author | first author of the primary study and the journal name. |
n.g1 | number of subjects (nonsurvivor group). |
q1.g1 | first quartile of the ASAT levels (nonsurvivor group). |
med.g1 | median ASAT level (nonsurvivor group). |
q3.g1 | third quartile of the ASAT levels (nonsurvivor group). |
mean.g1 | mean ASAT level (nonsurvivor group). |
sd.g1 | standard deviation of the ASAT levels (nonsurvivor group). |
n.g2 | number of subjects (survivor group). |
q1.g2 | first quartile of the ASAT levels (survivor group). |
med.g2 | median ASAT level (survivor group). |
q3.g2 | third quartile of the ASAT levels (survivor group). |
mean.g2 | mean ASAT level (survivor group). |
sd.g2 | standard deviation of the ASAT levels (survivor group). |
Katzenschlager S., Zimmer A.J., Gottschalk C., Grafeneder J., Seitel A., Maier-Hein L., Benedetti A., Larmann J., Weigand M.A., McGrath S., and Denkinger C.M. (2021). Can we predict the severe course of COVID-19 - A systematic review and meta-analysis of indicators of clinical outcome? PLOS One, 16, e0255154.